Croatia Oncology NGS Market (2025-2031) | Forecast, Segmentation, Analysis, Growth, Outlook, Value, Size & Revenue, Companies, Trends, Industry, Share, Competitive Landscape

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Croatia Country Macro Economic Indicators

3.2 Croatia Oncology NGS Market Revenues & Volume, 2021 & 2031F

3.3 Croatia Oncology NGS Market - Industry Life Cycle

3.4 Croatia Oncology NGS Market - Porter's Five Forces

3.5 Croatia Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 Croatia Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 Croatia Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F

3.8 Croatia Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.9 Croatia Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidences of cancer in Croatia

4.2.2 Growing adoption of Next-Generation Sequencing (NGS) technology in oncology

4.2.3 Rising demand for personalized medicine and targeted therapies

4.3 Market Restraints

4.3.1 High cost associated with NGS technology

4.3.2 Limited reimbursement policies for NGS-based tests in Croatia

4.3.3 Lack of skilled professionals in oncology NGS testing

6.1 Croatia Oncology NGS Market, By Technology

6.1.1 Overview and Analysis

6.1.2 Croatia Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 Croatia Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.1.4 Croatia Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.2 Croatia Oncology NGS Market, By Application

6.2.1 Overview and Analysis

6.2.2 Croatia Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F

6.2.3 Croatia Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F

6.3 Croatia Oncology NGS Market, By Service

6.3.1 Overview and Analysis

6.3.2 Croatia Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F

6.3.3 Croatia Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F

6.4 Croatia Oncology NGS Market, By Workflow

6.4.1 Overview and Analysis

6.4.2 Croatia Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.4.3 Croatia Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F

6.4.4 Croatia Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F

6.5 Croatia Oncology NGS Market, By End-use

6.5.1 Overview and Analysis

6.5.2 Croatia Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F

6.5.3 Croatia Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F

6.5.4 Croatia Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F

6.5.5 Croatia Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F

6.5.6 Croatia Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F

7.1 Croatia Oncology NGS Market Export to Major Countries

7.2 Croatia Oncology NGS Market Imports from Major Countries

8.1 Average turnaround time for NGS testing in oncology

8.2 Number of clinical trials utilizing NGS technology in Croatia

8.3 Rate of adoption of NGS-based tests by oncologists in Croatia

9.1 Croatia Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 Croatia Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 Croatia Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F

9.4 Croatia Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.5 Croatia Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 Croatia Oncology NGS Market Revenue Share, By Companies, 2024

10.2 Croatia Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters